학술논문
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model
Document Type
Article
Author
Source
In: International Journal of Cancer . (International Journal of Cancer, 15 January 2019, 144(2):345-354)
Subject
Language
English
ISSN
10970215
00207136
00207136